Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells

Rho-associated coiled-coil kinase (ROCK) signaling and disease

(2013) Alice V. Schofield et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex

(2013) Jing Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme

(2013) Ibrahim Erkutlu et al.   TUMOR BIOLOGY

Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration

(2012) Yanran Liang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Investigation of the performance of PEG–PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro

(2012) Yunyun Liu et al.   BRAIN RESEARCH

MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug Temozolomide

(2012) Shuguang Zhang et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System

(2011) B. A. Kohler et al.   JNCI-Journal of the National Cancer Institute

Cancer invasion and resistance: interconnected processes of disease progression and therapy failure

(2011) Stephanie Alexander et al.   TRENDS IN MOLECULAR MEDICINE

Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo

(2010) Lin Deng et al.   CANCER BIOLOGY & THERAPY

Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma

(2010) P. Gabelloni et al.   NEUROSCIENCE

Rocks are expressed in brain tumors and are required for glioma-cell migration on myelinated axons

(2008) Patrick Oellers et al.   GLIA